National Health Investors, Inc. (NHI) Receives “Hold” Rating from KeyCorp
A number of other brokerages have also weighed in on NHI. BidaskClub raised National Health Investors from a sell rating to a hold rating in a research report on Thursday, August 17th. Zacks Investment Research raised National Health Investors from a sell rating to a hold rating in a research report on Wednesday, August 9th. Finally, Mizuho reissued a neutral rating on shares of National Health Investors in a research report on Wednesday, June 28th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and two have assigned a buy rating to the company. The stock currently has a consensus rating of Hold and an average target price of $80.50.
National Health Investors (NYSE:NHI) opened at 79.99 on Friday. The company has a market cap of $3.28 billion, a price-to-earnings ratio of 20.54 and a beta of 0.56. The company’s 50-day moving average is $78.56 and its 200 day moving average is $75.95. National Health Investors has a 52-week low of $66.31 and a 52-week high of $81.29.
National Health Investors (NYSE:NHI) last issued its earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.29 by ($0.36). National Health Investors had a return on equity of 12.56% and a net margin of 59.24%. The business had revenue of $69.84 million during the quarter, compared to analysts’ expectations of $67.68 million. During the same period last year, the firm posted $1.22 EPS. National Health Investors’s quarterly revenue was up 14.1% compared to the same quarter last year. Equities analysts forecast that National Health Investors will post $3.85 earnings per share for the current fiscal year.
TRADEMARK VIOLATION WARNING: “National Health Investors, Inc. (NHI) Receives “Hold” Rating from KeyCorp” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this article can be read at https://www.thecerbatgem.com/2017/09/18/national-health-investors-inc-nhi-receives-hold-rating-from-keycorp.html.
The company also recently declared a quarterly dividend, which will be paid on Friday, November 10th. Shareholders of record on Friday, September 29th will be paid a dividend of $0.95 per share. The ex-dividend date is Thursday, September 28th. This represents a $3.80 dividend on an annualized basis and a dividend yield of 4.75%. National Health Investors’s dividend payout ratio is currently 97.69%.
In related news, insider Kevin Carlton Pascoe sold 2,000 shares of the business’s stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $79.80, for a total transaction of $159,600.00. Following the completion of the transaction, the insider now directly owns 21,228 shares in the company, valued at approximately $1,693,994.40. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 5.19% of the company’s stock.
Hedge funds have recently bought and sold shares of the business. Schwab Charles Investment Management Inc. boosted its stake in National Health Investors by 9.7% in the 1st quarter. Schwab Charles Investment Management Inc. now owns 161,309 shares of the real estate investment trust’s stock worth $11,716,000 after purchasing an additional 14,297 shares during the period. BlackRock Inc. boosted its stake in National Health Investors by 6,473.4% in the 1st quarter. BlackRock Inc. now owns 3,328,567 shares of the real estate investment trust’s stock worth $241,753,000 after purchasing an additional 3,277,930 shares during the period. Bank of America Corp DE boosted its stake in National Health Investors by 2.5% in the 1st quarter. Bank of America Corp DE now owns 388,780 shares of the real estate investment trust’s stock worth $28,238,000 after purchasing an additional 9,538 shares during the period. Daiwa Securities Group Inc. boosted its stake in National Health Investors by 1.7% in the 1st quarter. Daiwa Securities Group Inc. now owns 3,200 shares of the real estate investment trust’s stock worth $232,000 after purchasing an additional 55 shares during the period. Finally, Tocqueville Asset Management L.P. boosted its stake in National Health Investors by 2.3% in the 2nd quarter. Tocqueville Asset Management L.P. now owns 4,400 shares of the real estate investment trust’s stock worth $348,000 after purchasing an additional 100 shares during the period. Institutional investors and hedge funds own 70.67% of the company’s stock.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Stock Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related stocks with our FREE daily email newsletter.